10/21/22 |
NCI |
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors |
Link |
NIH NOSI |
Application due: 10/09/24 |
07/22/22 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
05/07/24 |
NCI |
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/18/24 |
08/02/22 |
NCI |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/11/24 |
05/07/24 |
NCI |
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
01/09/23 |
NCI |
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
06/05/23 |
NCI |
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers |
Link |
NIH NOSI |
Application due: 07/02/25 |
04/02/21 |
NCI |
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/18/24 |
10/04/23 |
NCI |
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
Link |
NIH NOSI |
Application due: 09/08/24 |
09/10/21 |
NCI |
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
02/04/22 |
NCI |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
12/05/22 |
NCI |
Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) |
Link |
NIH |
Application due: 06/14/24 |
12/13/23 |
NCI |
Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) |
Link |
NIH NOSI |
Application due: 09/25/24 |
01/17/24 |
NCI |
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease |
Link |
NIH NOSI |
Application due: 05/10/27 |
10/14/22 |
NCI |
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
Link |
NIH |
LOI due: 11/28/2022 |
04/10/23 |
NCI |
Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
09/18/20 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 No Independent Clinical Trials) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
07/22/22 |
NCI |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/16/22 |
NCI |
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/29/24 |
03/08/23 |
NCI |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/17/24 |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
08/11/23 |
NCI |
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 07/01/24 |
08/02/22 |
NCI |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
03/11/24 |
NCI |
Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities |
Link |
NIH NOSI |
Application due: 10/10/26 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
Link |
NIH NOSI |
Application due: 05/01/25 |
07/08/22 |
NCI |
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
08/02/22 |
NCI |
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
07/01/22 |
NCI |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 08/21/24 |
06/12/23 |
NCI |
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) |
Link |
NIH |
|
08/04/22 |
NCI |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) |
Linnk |
NIH |
Standard due dates apply |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences |
Link |
NIH NOSI |
Application due: 05/08/29 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program |
Link |
NIH NOSI |
Application due: 01/08/25 |
04/26/23 |
NCI |
Cancer Immunoprevention Network (CIP-Net) Research Projects (UG3/UH3 Clinical Trials Not Allowed) |
Link |
NIH |
Application due: 07/03/24 |
08/02/22 |
NCI |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
10/14/22 |
NCI |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
09/18/20 |
NCI |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
01/17/24 |
NCI |
Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences |
Link |
NIH NOSI |
Application due: 05/08/29 |
04/10/23 |
NCI |
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/29/23 |
NCI |
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates |
03/31/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care |
Link |
NIH NOSI |
Application due: 06/05/24 |
04/01/22 |
NCI |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
08/11/23 |
NCI |
Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings |
Link |
NIH NOSI |
Application due: 11/18/25 |
09/18/20 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials) |
Link |
NIH |
Standard due dates apply |
12/13/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
09/15/22 |
NCI |
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) |
Link |
NIH |
Application due: 07/01/24 |
09/15/22 |
NCI |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
Link |
NIH |
Application due: 06/20/24 |
12/13/23 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/01/22 |
NCI |
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity |
Link |
NIH NOSI |
Application due: 11/29/24 |
11/28/20 |
NCI |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
07/27/23 |
NCI |
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects |
Link |
NIH NOSI |
Application due: 05/09/24 |
10/30/23 |
NCI |
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research |
Link |
NIH NOSI |
Application due: 07/31/27 |
08/02/22 |
NCI |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/11/24 |
03/11/24 |
NCI |
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Application due: 06/14/24 |
07/22/22 |
NCI |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
Link |
NIH |
Application due: 06/12/24 |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplements for NCI Center for Global Health Research Programs |
Link |
NIH NOSI |
Application due: 05/23/24 |
06/26/23 |
NCI |
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies |
Link |
NIH NOSI |
Application due: 09/08/26 |
07/15/22 |
NCI |
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates |
01/17/24 |
NCI |
Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable |
Link |
NIH NOSI |
Application due: 10/01/25 |
06/17/22 |
NCI |
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research |
Link |
NIH NOSI |
Application due: 06/14/24 |
12/20/22 |
NCI |
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
07/22/22 |
NCI |
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
Link |
NIH |
Standard due dates apply |
10/04/23 |
NCI |
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/08/22 |
NCI |
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) |
Link |
NIH |
Standard due dates apply |
08/04/22 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
05/07/24 |
NCI |
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
Link |
NIH |
Standard due dates apply |
04/17/20 |
National Science Foundation |
NSF Rapid Response Research (RAPID) - various opps |
Link |
NSF COVID-19 |
|
01/30/22 |
METAvivor |
METAvivor Research Grants (various) |
Link |
Foundation |
LOI due date varies by grant |
10/21/22 |
Mesothelioma Applied Research Foundation |
2022 Mesothelioma Research Grant |
Link |
Foundation |
LOI due: 11/21/2022 |